Global stocks retreat amid rising coronavirus cases

Published 17-JUL-2020 12:14 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

A gauge of global equity markets slid on Thursday as investors assessed the rising number of COVID-19 cases in many countries and elevated levels of unemployment claims heightened concerns of the economic fallout from the pandemic.

U.S. stock markets traded lower as technology shares eased after earlier this week California shut down its economy once again amid a spike in cases. Large caps including Microsoft or Apple led the decline and while retail sales data showed a resurgence in June, it was not enough to get investors excited.

The S%P 500 fell 0.34%, while the Nasdaq Composite eased 0.73%.

The S&P 500 trades just 5% below its record high from February as a “perfect economic rebound” has already been priced into stock valuations. The U.S. is currently reporting north of 60,000 new coronavirus cases a day.

ASX futures trade a mere 13 points higher after Asian markets declined earlier in the session. The local share market opened lower and finished throughout the day, leaving the ASX 200 0.69% or 42 points lower to be last quoted at 6,010.9 points.

Shanghai Composite falls 4.5%

Asian equities traded in red on Thursday, led lower by Chinese shares which fell a hefty 4.5%. The Hang Seng declined 2% while the Nikkei traded 0.76% lower.

Australia held up slightly better however the renewed coronavirus outbreak in Victoria has left an increasing number of investors on the side-line.

Reuters data showed that the S&P 500 has exceeded the Nasdaq by nearly 3 percentage points over the past week, its greatest five-day outperformance over the Nasdaq in months, reflecting a shift away from the technology heavyweights that have led Wall Street’s gains in recent months.

In Europe, investors were cautious as well with equities from London to Frankfurt in the red.

The FTSE 100 drifted lower after a poor Asian lead to close 0.67% lower after a 1.8% jump on Wednesday. In Frankfurt it was much the same as the DAX declined 0.43% to 12,874.97 points.

The pan-European STOXX Europe 600 Index traded 0.47% lower to 372.13 points. MSCI’s world equity index, which tracks shares in 49 nations, fell 0.72%.

Gold fell 1% just below US$1,800 as effectively all asset classes retreated. Crude Oil prices fell in unison with the Crude Oil Continuous Contract down 1.17% while Brent trade down only marginally.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X